Dugel Pravin's Form 4 filing
Ocular Therapeutix, Inc (OCUL) · filed Aug 26, 2026
- Accession no.
- 0001104659-26-101667
- Filed
- Aug 26, 2026, 5:56 PM ET
- Trade date
- Aug 24-25, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $233.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dugel PravinCIK 0001700917 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | Common Stock | SSaleDisposed | −21,649 | $10.77 | −$233,159.73 | 2,525,429 | Direct | |
| Aug 25, 2026 | Common Stock | GGiftDisposed | −50,092 | $0.00 | $0 | 0 | Indirect | |
| Aug 25, 2026 | Common Stock | GGiftAcquired | +50,092 | $0.00 | $0 | 744,903 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.